ask="83.55"
ask_size="2000"
average_daily_volume="602695"
bid="55.00"
bid_size="10000"
book_value="11.38"
change="+1.87"
change_from_200_day_moving_average="6.38"
change_from_50_day_moving_average="-2.27"
change_from_52_week_high="-21.43"
change_From_52_week_low="26.45"
change_in_percent="+2.63%"
close="72.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="74.18"
high_52_weeks="94.40"
last_trade_date="1/12/2017"
last_trade_price="72.97"
last_trade_size="100"
last_trade_time="4:00pm"
low="69.49"
low_52_weeks="46.52"
market_capitalization="2.98B"
moving_average_200_day="66.59"
moving_average_50_day="75.24"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="70.00"
pe_ratio="N/A"
peg_ratio="-0.39"
percent_change_from_200_day_moving_average="+9.59%"
percent_change_from_50_day_moving_average="-3.02%"
percent_change_from_52_week_high="-22.70%"
percent_change_from_52_week_low="+56.86%"
previous_close="71.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.25"
price_per_sales="22695.90"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="315225"
weeks_range_52="46.52 - 94.40"
